Amgen Hyderabad: New Technology and Innovation Hub Set to Transform Global Operations
Amgen Hyderabad: In a significant move to bolster its digital capabilities and enhance its global operations, Amgen has announced plans to open a new technology and innovation site in Hyderabad, India. The new site, aptly named Amgen India, is set to become a pivotal part of the company’s global strategy, focusing on accelerating the development of cutting-edge digital solutions and advancing its robust pipeline of medicines.
Why Hyderabad? The Strategic Choice for Amgen India
Hyderabad, known as the pharmaceutical and biotechnology hub of India, was carefully selected for Amgen’s new venture due to its rich pool of talent in medicine, life sciences, data sciences, and artificial intelligence (AI). The city’s reputation as a growing tech hub, particularly in the rapidly advancing field of AI, aligns perfectly with Amgen’s vision for innovation and growth.
David M. Reese, MD, Executive Vice President and Chief Technology Officer at Amgen, emphasized the importance of this strategic location. “Hyderabad offers world-class talent and has a thriving ecosystem for technology and life sciences. This new site will allow us to work with greater speed, confidence, and efficiency, propelling our mission to serve patients worldwide.”
A Hub for Innovation: What Amgen India Will Offer
Amgen India will be situated in Hitec City, a prominent IT suburb of Hyderabad, occupying six floors of the RMZ Spire Tower 110. The site is designed to accommodate up to 3,000 employees, making it one of Amgen’s largest global hubs. The facility is expected to be operational by the fourth quarter of 2024, providing a state-of-the-art environment for innovation and collaboration.
The primary focus of Amgen India will be to develop and scale new technology solutions that enhance efficiencies across Amgen’s global enterprise. This includes roles that will strengthen key areas of Amgen’s business, such as AI, data science, life science, and other global capabilities. The site will not only support the company’s existing operations but will also serve as a launchpad for future innovations in biotechnology and digital health.
Amgen’s Vision: Merging Biotechnology with Technology
Amgen’s decision to establish a significant presence in India is part of a broader strategy to merge biotechnology with technology, a convergence that the company believes is critical for addressing the needs of an aging global population. “The convergence of biotechnology and technology is enabling Amgen to innovate with unprecedented speed and precision,” said Reese. “This site represents more than a decade of preparation and reflects our commitment to leveraging global talent to serve patients better.”
Looking Ahead: The Future Impact of Amgen India
As Amgen India gears up to become operational, the site is poised to play a crucial role in the company’s global strategy. By harnessing the technological expertise available in Hyderabad, Amgen aims to push the boundaries of what is possible in biotechnology, driving advancements that could have a significant impact on healthcare worldwide.
The establishment of Amgen India marks a significant milestone in the company’s journey towards innovation and excellence. As the site develops, it will likely become a beacon of technological advancement and a testament to Amgen’s commitment to improving patient outcomes through innovation.
This move not only highlights Amgen’s strategic vision but also underscores Hyderabad’s growing importance as a global hub for technology and life sciences, setting the stage for future collaborations and breakthroughs in the biotech industry.
